220 related articles for article (PubMed ID: 15764751)
1. Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome.
Sakurai S; Nishijima T; Takahashi S; Yamauchi K; Arihara Z; Takahashi K
Chest; 2005 Mar; 127(3):731-7. PubMed ID: 15764751
[TBL] [Abstract][Full Text] [Related]
2. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome.
Igarashi N; Tatsumi K; Nakamura A; Sakao S; Takiguchi Y; Nishikawa T; Kuriyama T
Chest; 2003 Oct; 124(4):1381-5. PubMed ID: 14555569
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome.
Sakurai S; Nishijima T; Takahashi S; Yamauchi K; Arihara Z; Takahashi K
Respiration; 2004; 71(4):380-4. PubMed ID: 15316212
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic values of serum orexin-A levels in children with obstructive sleep apnea-hypopnea syndrome].
Abulaiti A; Xu PR; Duo LK
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):291-6. PubMed ID: 19099733
[TBL] [Abstract][Full Text] [Related]
5. [The changes and implications of plasma orexin-A levels in patients with obstructive sleep apnea-hypopnea syndrome].
Liao XM; Yu Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jun; 28(6):368-71. PubMed ID: 16008971
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma levels of orexin-A in sleep apnea.
Busquets X; Barbé F; Barceló A; de la Peña M; Sigritz N; Mayoralas LR; Ladaria A; Agustí A
Respiration; 2004; 71(6):575-9. PubMed ID: 15627867
[TBL] [Abstract][Full Text] [Related]
7. [Plasma orexin-A level in patients with obstructive apnea-hypopnea syndrome].
Yao X; Yang H; Zhang G; Tang Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jun; 20(12):547-9. PubMed ID: 16941964
[TBL] [Abstract][Full Text] [Related]
8. [Short-term and long-term influences of nasal continuous positive airway pressure to sleep architecture of obstructive sleep apnea hypopnea syndrome].
Xiao YL; Richter F; Brunner F; Lerche B; Zhang DP; Zheng PD
Zhonghua Nei Ke Za Zhi; 2004 Sep; 43(9):651-3. PubMed ID: 15500774
[TBL] [Abstract][Full Text] [Related]
9. Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome.
Nishijima T; Sakurai S; Arihara Z; Takahashi K
Peptides; 2003 Mar; 24(3):407-11. PubMed ID: 12732338
[TBL] [Abstract][Full Text] [Related]
10. Response shift in perception of sleepiness in obstructive sleep apnea-hypopnea syndrome before and after treatment with nasal CPAP.
Chin K; Fukuhara S; Takahashi K; Sumi K; Nakamura T; Matsumoto H; Niimi A; Hattori N; Mishima M; Nakamura T
Sleep; 2004 May; 27(3):490-3. PubMed ID: 15164904
[TBL] [Abstract][Full Text] [Related]
11. [The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease].
Zhang J; Tan H; Shi XN; Zheng XW; Li YM; Li SF; Ma ZY
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):188-91. PubMed ID: 16624147
[TBL] [Abstract][Full Text] [Related]
12. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
[TBL] [Abstract][Full Text] [Related]
13. [Association between plasma interleukin-18 levels and atherosclerosis in patients with sleep apnea hypopnea syndrome].
Li C; Zhang XL; Liu H; Wang ZG; Yin KS
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Dec; 30(12):908-11. PubMed ID: 18336766
[TBL] [Abstract][Full Text] [Related]
14. Effect of continuous positive airway pressure treatment on elderly Chinese patients with obstructive sleep apnea in the prethrombotic state.
Zhang X; Yin K; Wang H; Su M; Yang Y
Chin Med J (Engl); 2003 Sep; 116(9):1426-8. PubMed ID: 14527381
[TBL] [Abstract][Full Text] [Related]
15. [Detection of thromboxane B2, 6-keto-prostaglandin F1alpha and anticardiolipin antibody in patients with obstructive sleep apnea-hypopnea syndrome].
Wu KJ; An ZY; Guan JT; Zhang CM; Feng HP; Yang LJ; Wang BF
Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):320-3. PubMed ID: 15196341
[TBL] [Abstract][Full Text] [Related]
16. [Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].
Sun L; Chen R; Wang J; Zhang Y; Li J; Peng W; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3483-7. PubMed ID: 25622738
[TBL] [Abstract][Full Text] [Related]
17. Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure.
Gasa M; Tamisier R; Launois SH; Sapene M; Martin F; Stach B; Grillet Y; Levy P; Pepin JL;
J Sleep Res; 2013 Aug; 22(4):389-97. PubMed ID: 23409736
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea.
Sánchez-de-la-Torre M; Barceló A; Piérola J; Esquinas C; de la Peña M; Durán-Cantolla J; Capote F; Masa JF; Marin JM; Vilá M; Cao G; Martinez M; de Lecea L; Gozal D; Montserrat JM; Barbé F
Respir Med; 2011 Dec; 105(12):1954-60. PubMed ID: 21889324
[TBL] [Abstract][Full Text] [Related]
19. [Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome].
Wang YN; Yang Y; Luo YQ; Chen LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):666-9. PubMed ID: 16708805
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma levels of soluble (pro)renin receptor in patients with obstructive sleep apnea syndrome: association with polysomnographic parameters.
Nishijima T; Tajima K; Takahashi K; Sakurai S
Peptides; 2014 Jun; 56():14-21. PubMed ID: 24657284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
